HEY ALL if I could get some clarification:
1) Do institutions / investors have to report 13-G 13-D if there is no BOD? (If there is a link I’d gladly appreciate it)
2) If shares are to be canceled wouldn’t they have reported that by now and not played the game of egg shells around shareholders?
3) If there is clear evidence for institutions buying shares, if love to see a link and confirmation.
4) Do the NOLs get eliminated if commons are canceled. And what’s the true value of the NOLs?
5) For those short or no longer holding BIOAQ shares, have any of you spoken to PWC, FINRA, anyone from Visolis / LCY, or anyone from the Canadian courts that have 100% confirmed cancelation if equity?
6) Does “Residual value” stated in the (10/24) 8K only refer to value of assets or does that include anything that pertains to common equity. Would that involve no “residual value” through an R/M which I wouldn’t see as feasible.
Any response is greatly appreciated!
GLTA
GO BIOA!
